Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2004

View Archived Issues

Assessment of the pharmacokinetics and pharmacodynamics of UK-427857

New beta-secretase inhibitors prepared and tested at GSK

Incyte researchers present novel chemokine CCR2/CCR5 antagonists

Novel tachykinin NK3 antagonists with potential in CNS conditions

Actelion claims new sulfamide-based endothelin antagonists

Novel cannabinoid CB2 agonists under study at Sanofi-Synthelabo

Isis scientists describe new anti-HCV agents targeting IRES

Novel protein kinase inhibitors and their use in cancer therapy

Update on the safety and pharmacokinetics of SRA-333

Therapeutic benefits found with rosiglitazone in patients with early AD

Clinical data support the development of immunotherapeutic strategies for AD

New 12-week labeling information approved for Seroquel

Abbott and Deltanoid to develop fourth generation active D therapies

KaloBios inlicenses antibody drug candidate for autoimmune diseases

FDA approves Alinia tablets for adults

Seed financing round at TheraQuest supports progression of TQ-1015

Gene Logic acquires technology program from Millennium

Hemispherx Biopharma accelerates development of Alferon N

New phase II biomarker trial for SGN-15

Fast track status for subcutaneous icatibant in HAE

Pivotal trial cleared for Liberte paclitaxel-eluting coronary stent

New study evaluates effects of chromium picolinate in pre-diabetes patients

Potent and selective FXa inhibitors reported by Pfizer

Promising antiarthritic effects for methionine aminopeptidase-2 inhibitor

Novel anti-prion agent effective against experimental scrapie in vivo

Specific oral PI3K inhibitor blocks neutrophil trafficking and activation in vivo

Ezetimibe/simvastatin approved by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...